Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation routing
Prioritisation routing
None selected (376)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (295)
Apply filters
Showing 291 to 300 of 376
Sort by
Decision date
Title
Apply sorting
Topic prioritisation
Title
Prioritisation routing
Decision
Decision date
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)
None selected
Not selected
30 March 2022
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)
None selected
Not selected
30 March 2022
Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)
None selected
Not selected
30 March 2022
d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696)
None selected
Not selected
4 March 2022
The Insides System chyme reinfusion system (MT682)
None selected
Not selected
4 March 2022
Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723]
None selected
Not selected
3 March 2022
Darunavir plus cobicistat fixed dose combination for paediatric human immunodeficiency virus 1 infection [TSID10722]
None selected
Not selected
3 March 2022
Prostate specific membrane antigen (PSMA) radiotherapy for treating advanced prostate cancer
None selected
Not selected
3 March 2022
Glatiramer acetate depot for multiple sclerosis [TSID10620]
None selected
Further information required
15 February 2022
Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TSID10574]
None selected
Not selected
10 February 2022
Previous page
1
…
28
29
Current page
30
31
32
…
38
Page
30
of
38
Next page
Results per page
10
25
50
All
Back to top